EGb 761
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EGb 761, covering 2024-03-07 to 2025-12-17. Get the full timeline:
Most recent: Clinical Trial Update: A Pilot Study to Examine the Effect of Egb761 on Plasma Biomarker Levels and on Cognitive Function in Patients With MCI [Phase 2]